COMPANY
Field Medical
Timeline
- Trial start Not phased (device or behavioral study): This Study Will Evaluate if the Field Force Pulsed Field Ablation System is Safe and Effective for Treating Sustained Monomorphic Ventricular Tachycardia, a Potentially Serious Fast Heart Rhythm source ↗
- Trial start Not phased (device or behavioral study): The Field PULSE Study source ↗
- Trial start Not phased (device or behavioral study): Ventricular Catheter Ablation Study (VCAS) source ↗
Upcoming milestones
- Jun 30, 2027 (ESTIMATED) · Not phased · The Field PULSE Study · NCT06452589
- 2027-08 (ESTIMATED) · Not phased · This Study Will Evaluate if the Field Force Pulsed Field Ablation System is Safe and Effective for Treating Sustained Monomorphic Ventricular Tachycardia, a Potentially Serious Fast Heart Rhythm of th · NCT07794215
Clinical trials (lead sponsor) 3
| Record | Title | Phase | Status | Start | Primary completion |
|---|---|---|---|---|---|
| NCT07794215 | This Study Will Evaluate if the Field Force Pulsed Field Ablation System is Safe and Effective for Treating Sustained Monomorphic Ventricular Tachycardia, a Potentially Serious Fast Heart Rhythm of the Heart. The Treatment Uses Short Pulses of Energy to Target and Destroy the Heart Tissue Causing VT | Not phased (device or behavioral study) | Not yet recruiting | 2026-12 | 2027-08 (estimated) |
| NCT06203262 | Ventricular Catheter Ablation Study (VCAS) | Not phased (device or behavioral study) | Completed | Apr 12, 2024 | Oct 31, 2025 (actual) |
| NCT06452589 | The Field PULSE Study | Not phased (device or behavioral study) | Active, not recruiting | Jul 25, 2024 | Jun 30, 2027 (estimated) |